Deep Track Capital
North America, Connecticut, United States, Greenwich
Description
Deep Track Capital is an investment firm that focuses solely on the life sciences sector.
Investor Profile
Deep Track Capital has made 76 investments, with 24 in the past 12 months and 16% as lead.
Stage Focus
- Post Ipo Equity (51%)
- Series B (25%)
- Series C (12%)
- Series A (5%)
- Series E (3%)
- Series D (3%)
- Undisclosed (1%)
Country Focus
- United States (82%)
- Canada (5%)
- France (5%)
- United Kingdom (4%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
- Germany (1%)
- Denmark (1%)
Industry Focus
- Biotechnology
- Health Care
- Therapeutics
- Pharmaceutical
- Medical
- Biopharma
- Life Science
- Oncology
- Genetics
- Medical Device
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
